Home / Drug shortages / Amantadine Hydrochloride Capsule

Amantadine Hydrochloride Capsule — FDA Drug Shortage

To Be Discontinued — Upsher-Smith Laboratories, LLC

The FDA lists a drug shortage record for Amantadine Hydrochloride Capsule (capsule) from Upsher-Smith Laboratories, LLC with status To Be Discontinued. The shortage was first posted on 07/23/2025.

Shortage Details

Status
To Be Discontinued
Company
Upsher-Smith Laboratories, LLC
Package NDC
0832-1015-50
Dosage Form
Capsule
Presentation
Amantadine Hydrochloride, Capsule, 100 mg (NDC 0832-1015-50)
Initial Posting
07/23/2025
Revised Date

FDA data resources